Drug Trial Radar · NCT03754049
A Phase 2, Open Label, Pharmacokinetic (PK) Study of TLC599 in Subjects With Osteoarthritis of the Knee
Last checked: Nov 19, 2026Latest source record: Oct 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
102
Actual
Start
Jan 21, 2019
Primary completion
Nov 7, 2023
Study completion Nov 7, 2023
Sponsor
- Lead sponsor
- Taiwan Liposome CompanyIndustry
- Sponsor type
- Industry
- First posted
- Nov 27, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is a multi-center, Phase 2, open-label, 1-period, parallel study with 9 cohorts of subjects with osteoarthritis (OA) of the knee enrolled to receive single-dose of TLC599 or Dexamethasone sodium phosphate (DSP) via IA injection and 1 cohort of healthy subjects to receive single-dose of DSP via intravenous (IV) injection.
Conditions
- Osteoarthritis of the Knee
Interventions
TLC599Drug
TLC599 is manufactured with the proprietary lipid formulation in lyophilized form (BioSeizer) for the reconstitution with the aqueous DSP (active ingredient).
DSPDrug
Dexamethasone sodium phosphate (DSP) is a glucocorticoid widely used in the treatment of joint pain such as gout, osteoarthritis and rheumatoid arthritis via IA injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under the Curve [AUC]Time frame: Baseline till 24 weeks post investigational product (IP) administration
- Cmax: maximum concentrationTime frame: Baseline till 24 weeks post IP administration
- Tmax: time to peak concentrationTime frame: Baseline till 24 weeks post IP administration
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
Arizona Research Center
Phoenix, Arizona
Panax Clinical Research
Miami, Florida
South Coast Research Center
Miami, Florida
Syneos Health
Miami, Florida
Clinical Trials of South Carolina
Charleston, South Carolina
Futuro Clinical Trials, LLC.
McAllen, Texas
JBR Clinical Research
Salt Lake City, Utah
China Medical University Hospital
Taichung, Taiwan
Tri-Service General Hospital
Taipei, Taiwan
Taipei Municipal Wanfang Hospital
Taipei, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.